| P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells AW Farrell, S Gadeock, A Pupovac, B Wang, I Jalilian, M Ranson, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1800 (11), 1173-1182, 2010 | 53 | 2010 |
| Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer R Shu, VJ Evtimov, MV Hammett, NYN Nguyen, J Zhuang, PJ Hudson, ... Molecular Therapy-Oncolytics 20, 325-341, 2021 | 48 | 2021 |
| Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells A Pupovac, NJ Geraghty, D Watson, R Sluyter Immunology and cell biology 93 (1), 77-85, 2015 | 42 | 2015 |
| Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptors JNSN Tran, A Pupovac, RM Taylor, JS Wiley, SN Byrne, R Sluyter Experimental Dermatology 19 (8), e151-e157, 2010 | 34 | 2010 |
| Human P2X7 receptor activation induces the rapid shedding of CXCL16 A Pupovac, CM Foster, R Sluyter Biochemical and Biophysical Research Communications 432 (4), 626-631, 2013 | 33 | 2013 |
| P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells S Gadeock, A Pupovac, V Sluyter, M Spildrejorde, R Sluyter Purinergic signalling 8, 669-676, 2012 | 29 | 2012 |
| Roles of extracellular nucleotides and P2 receptors in ectodomain shedding A Pupovac, R Sluyter Cellular and molecular life sciences 73, 4159-4173, 2016 | 25 | 2016 |
| CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation A Pupovac, L Stokes, R Sluyter Purinergic signalling 9, 609-619, 2013 | 23 | 2013 |
| Enhancing a natural killer: Modification of NK cells for cancer immunotherapy R Islam, A Pupovac, V Evtimov, N Boyd, R Shu, R Boyd, A Trounson Cells 10 (5), 1058, 2021 | 22 | 2021 |
| An antigen to remember: regulation of B cell memory in health and disease A Pupovac, KL Good-Jacobson Current opinion in immunology 45, 89-96, 2017 | 22 | 2017 |
| Group A Streptococcus modulates host inflammation by manipulating polymorphonuclear leukocyte cell death responses JA Tsatsaronis, D Ly, A Pupovac, O Goldmann, M Rohde, JM Taylor, ... Journal of Innate Immunity 7 (6), 612-622, 2015 | 13 | 2015 |
| CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies V To, VJ Evtimov, G Jenkin, A Pupovac, AO Trounson, RL Boyd Frontiers in Immunology 13, 968395, 2022 | 10 | 2022 |
| ‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells N Boyd, K Cartledge, H Cao, V Evtimov, A Pupovac, A Trounson, R Boyd Cells 10 (10), 2631, 2021 | 9 | 2021 |
| Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy R Shu, M Hammett, V Evtimov, A Pupovac, NY Nguyen, R Islam, J Zhuang, ... Bioengineering & Translational Medicine 8 (6), e10571, 2023 | | 2023 |
| Transcriptional and epigenetic regulation of germinal centre and plasma cell differentiation K Good-Jacobson, A Di Pietro, A Pupovac EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1072-1072, 2016 | | 2016 |
| Memory B cell subset formation in acute and chronic viral disease A Pupovac, K Good-Jacobson EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1128-1128, 2016 | | 2016 |
| Front & Back Matter TE O'Sullivan, MM Berrien-Elliott, JA Wagner, TA Fehniger, JY Wu, ... Journal of Innate Immunity 7 (6), 2015 | | 2015 |
| P2X7 receptor-induced CD23 shedding from B cells A Pupovac | | 2014 |
| Human P2X7 receptor activation induces ADAM10-mediated shedding of CD23 and CXCL16 (P4137) A Pupovac, B Wang, C Foster, R Sluyter The Journal of Immunology 190 (1_Supplement), 112.2-112.2, 2013 | | 2013 |
